WALTHAM, Mass., Nov. 5, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq:SNDX), today announced that multiple abstracts evaluating Niktimvo™ (axatilimab-csfr), an anti-CSF-1R antibody for the ...
Leveraging AI to help analyze and visualize data gathered from a variety of data sets enables data-driven insights and fast analysis without the high costs of talent and technology. In today's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback